The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Exacerbations of Chronic Obstructive Pulmonary Disease
Abstract
Exacerbations of chronic obstructive pulmonary disease (COPD) cause morbidity, hospital admissions, and mortality, and strongly influence health-related quality of life. Some patients are prone to frequent exacerbations, which are associated with considerable physiologic deterioration and increased airway inflammation. About half of COPD exacerbations are caused or triggered primarily by bacterial and viral infections (colds, especially from rhinovirus), but air pollution can contribute to the beginning of an exacerbation. Type 1 exacerbations involve increased dyspnea, sputum volume, and sputum purulence; Type 2 exacerbations involve any two of the latter symptoms, and Type 3 exacerbations involve one of those symptoms combined with cough, wheeze, or symptoms of an upper respiratory tract infection. Exacerbations are more common than previously believed (2.5-3 exacerbations per year); many exacerbations are treated in the community and not associated with hospital admission. We found that about half of exacerbations were unreported by the patients, despite considerable encouragement to do so, and, instead, were only diagnosed from patients' diary cards. COPD patients are accustomed to frequent symptom changes, and this may explain their tendency to underreport exacerbations. COPD patients tend to be anxious and depressed about the disease and some might not seek treatment. At the beginning of an exacerbation physiologic changes such as decreases in peak flow and forced expiratory volume in the first second (FEV(1)) are usually small and therefore are not useful in predicting exacerbations, but larger decreases in peak flow are associated with dyspnea and the presence of symptomatic upper-respiratory viral infection. More pronounced physiologic changes during exacerbation are related to longer exacerbation recovery time. Dyspnea, common colds, sore throat, and cough increase significantly during prodrome, indicating that respiratory viruses are important exacerbation triggers. However, the prodrome is relatively short and not useful in predicting onset. As colds are associated with longer and more severe exacerbations, a COPD patient who develops a cold should be considered for early therapy. Physiologic recovery after an exacerbation is often incomplete, which decreases health-related quality of life and resistance to future exacerbations, so it is important to identify COPD patients who suffer frequent exacerbations and to convince them to take precautions to minimize the risk of colds and other exacerbation triggers. Exacerbation frequency may vary with the severity of the COPD. Exacerbation frequency may or may not increase with the severity of the COPD. As the COPD progresses, exacerbations tend to have more symptoms and take longer to recover from. Twenty-five to fifty percent of COPD patients suffer lower airway bacteria colonization, which is related to the severity of COPD and cigarette smoking and which begins a cycle of epithelial cell damage, impaired mucociliary clearance, mucus hypersecretion, increased submucosal vascular leakage, and inflammatory cell infiltration. Elevated sputum interleukin-8 levels are associated with higher bacterial load and faster FEV(1) decline; the bacteria increase airway inflammation in the stable patient, which may accelerate disease progression. A 2-week course of oral corticosteroids is as beneficial as an 8-week course, with fewer adverse effects, and might extend the time until the next exacerbation. Antibiotics have some efficacy in treating exacerbations. Exacerbation frequency increases with progressive airflow obstruction; so patients with chronic respiratory failure are particularly susceptible to exacerbation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Vincken, W., van Noord, J. A., Greefhorst, A. P. M., Bantje, T. A., Kesten, S., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238702 · Cited by 736
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Patel, I. S. (2002) · Thorax · doi:10.1136/thorax.57.9.759 · Cited by 690
Davies, L., Angus, R., & Calverley, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11326-0 · Cited by 595
KANNER, R. E., ANTHONISEN, N. R., & CONNETT, J. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2010017 · Cited by 583
Airway eosinophilia in chronic bronchitis during exacerbations.
Saetta, M., Di Stefano, A., Maestrelli, P., Turato, G., Ruggieri, M. P., Roggeri, A., Calcagni, P., Mapp, C. E., Ciaccia, A., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952628 · Cited by 536
Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD
Stockley, R. A., O’Brien, C., Pye, A., & Hill, S. L. (2000) · Chest · doi:10.1378/chest.117.6.1638 · Cited by 535
Rohde, G. (2003) · Thorax · doi:10.1136/thorax.58.1.37 · Cited by 524
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Meecham Jones, D. J., Paul, E. A., Jones, P. W., & Wedzicha, J. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633704 · Cited by 479
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Nasal Intermittent Positive Pressure Ventilation
Leger, P., Marie Bedicam, J., Cornette, A., Reybet-Degat, O., Langevin, B., Robert, D., Marie Polu, J., & Jeannin, L. (1994) · Chest · doi:10.1378/chest.105.1.100 · Cited by 439
Hill, A. T., Campbell, E. J., Hill, S. L., Bayley, D. L., & Stockley, R. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00507-6 · Cited by 414
Subauste, M. C., Jacoby, D. B., Richards, S. M., & Proud, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118067 · Cited by 385
Nichol, K. L., Baken, L., & Nelson, A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00003 · Cited by 385
Airway Bacterial Load and FEV 1 Decline in Patients with Chronic Obstructive Pulmonary Disease
Wilkinson, T. M. A., Patel, I. S., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1179oc · Cited by 370
Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations: A Meta-analysis
Saint, S. (1995) · JAMA · doi:10.1001/jama.1995.03520360071042 · Cited by 365
Enslein, K. (1978) · Technometrics · doi:10.1080/00401706.1978.10489655 · Cited by 362
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
Thompson, W. H., Nielson, C. P., Carvalho, P., Charan, N. B., & Crowley, J. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756814 · Cited by 341
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease
Seemungal, T. A. R., Harper-Owen, R., Bhowmik, A., Jeffries, D. J., & Wedzicha, J. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d19.x · Cited by 334
Time course of recovery of health status following an infective exacerbation of chronic bronchitis
Spencer, S. (2003) · Thorax · doi:10.1136/thorax.58.7.589 · Cited by 331
Rebuck, A. S., Chapman, K. R., Abboud, R., Pare, P. D., Kreisman, H., Wolkove, N., & Vickerson, F. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90378-0 · Cited by 266
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review
Poole, P. J., & Black, P. N. (2001) · BMJ · doi:10.1136/bmj.322.7297.1271 · Cited by 256
Respiratory Viral Infections in Adults With and Without Chronic Obstructive Pulmonary Disease
GREENBERG, S. B., ALLEN, M., WILSON, J., & ATMAR, R. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9911019 · Cited by 246
Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease
Donaldson, G. C., Seemungal, T., Jeffries, D. J., & Wedzicha, J. A. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13d25.x · Cited by 243
van Noord, J. A., de Munck, D. R. A. J., Bantje, T. A., Hop, W. C. J., Akveld, M. L. M., & Bommer, A. M. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e11.x · Cited by 211
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease
Zalacain, R., Sobradillo, V., Amilibia, J., Barron, J., Achotegui, V., Pijoan, J. I., & Llorente, J. L. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13b21.x · Cited by 210
Acute infective exacerbations of chronic bronchitis
(1995) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068984 · Cited by 200
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.
Okubadejo, A. A., Jones, P. W., & Wedzicha, J. A. (1996) · Thorax · doi:10.1136/thx.51.1.44 · Cited by 198
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
Roland, M. (2001) · Thorax · doi:10.1136/thorax.56.1.30 · Cited by 194
DOWSON, L. J., GUEST, P. J., & STOCKLEY, R. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2106036 · Cited by 179
Jarad, N. A., Wedzicha, J. A., Burge, P. S., & Calverley, P. M. A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90001-x · Cited by 160
Risk factors for lower airway bacterial colonization in chronic bronchitis
Monsó, E., Rosell, A., Bonet, G., Manterola, J. M., Cardona, P.-J., Ruíz, J., & Morera, J. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13b20.x · Cited by 153
Blasi, F. (2002) · Thorax · doi:10.1136/thorax.57.8.672 · Cited by 134
Health effects of an air pollution episode in London, December 1991.
Anderson, H. R., Limb, E. S., Bland, J. M., de León, A. P., Strachan, D. P., & Bower, J. S. (1995) · Thorax · doi:10.1136/thx.50.11.1188 · Cited by 132
Sachs, A. P. E., Koëter, G. H., Groenier, K. H., van der Waaij, D., Schiphuis, J., & Jong, B. M. (1995) · Thorax · doi:10.1136/thx.50.7.758 · Cited by 128
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency
Hill, A. T., Bayley, D., Campbell, E. J. M., Hill, S. L., & Stockley, R. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e12.x · Cited by 124
Aminophylline for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Rice, K. L., Leatherman, J. W., Duane, P. G., Snyder, L. S., Harmon, K. R., Abel, J., & Niewoehner, D. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-305 · Cited by 119
Jones, S. E., Packham, S., HEBDEN, M. H., & Smith, A. P. (1998) · Thorax · doi:10.1136/thx.53.6.495 · Cited by 117
Erythromycin Inhibits Rhinovirus Infection in Cultured Human Tracheal Epithelial Cells
Suzuki, T., Yamaya, M., Sekizawa, K., Hosoda, M., Yamada, N., Ishizuka, S., Yoshino, A., Yasuda, H., Takahashi, H., Nishimura, H., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.2103094 · Cited by 109
Okubadejo, A., O’Shea, L., Jones, P., & Wedzicha, J. A. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10071572 · Cited by 86
Linaker, C., Coggon, D., Holgate, S. T., Clough, J., Josephs, L., Chauhan, A. J., & Inskip, H. M. (2000) · Thorax · doi:10.1136/thorax.55.11.930 · Cited by 72
Chlamydia pneumoniae and COPD exacerbation
Seemungal, T. (2002) · Thorax · doi:10.1136/thorax.57.12.1087-a · Cited by 41
Cited by
COPD exacerbations {middle dot} 2: Aetiology
Sapey, E. (2006) · Thorax · doi:10.1136/thx.2005.041822 · Cited by 437
Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L., Brown, R. H., Feller-Kopman, D., Wise, R., & Biswal, S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002042 · Cited by 342
Ling, S. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s5098 · Cited by 338
Effective mucus clearance is essential for respiratory health
Randell, S. H., & Boucher, R. C. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0082sf · Cited by 335
Hospitalized Exacerbations of COPD
Müllerova, H., Maselli, D. J., Locantore, N., Vestbo, J., Hurst, J. R., Wedzicha, J. A., Bakke, P., Agusti, A., & Anzueto, A. (2015) · Chest · doi:10.1378/chest.14-0655 · Cited by 320
Metadata
- Venue
- Respiratory Infections
- Publisher
- CRC Press
- Published
- 2016-04-19
- Volume
- 48
- Issue
- 12
- Pages
- 64-80
- OpenAlex
- W1838585748
- Cited by
- 270
- References
- 52
- FWCI
- 122.70
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.